Skip to main content
. Author manuscript; available in PMC: 2008 Apr 6.
Published in final edited form as: Antivir Ther. 2006;11(8):1081–1089.

Table 2.

Measures of glucose metabolism while fasting and during 75 gm oral glucose challenge.

Week 4 Week 12 Week 24 Week 48
Fasting plasma glucose, mmol/L 5.47 (5.05, 5.74) 5.65 (5.3, 6.09) p=0.001 5.77 (5.32, 6.24) p=0.003 5.59 (5.24, 6.05) p=0.041
Fasting insulin, pmol/L 66 (38, 120) 83 (54, 128) p=0.046 104* (49, 153) p=0.003 99 (56, 131) p=0.016
HOMA IR, uU/ml × mmol/L 2.4 (1.3, 4.6) 3.1 (1.9, 5.4) p=0.034 3.9* (1.8, 6.5) p=0.002 3.5 (2.0, 5.2) p=0.009
Fructosamine, mmol/L 235 (222, 248) 230 (221, 245) p=0.13 239 (229, 246) p=0.4 234 (222, 252) p=0.5
OGTT
30-min glucose (mmol/L) 9.57 (8.08, 10.16) 9.13 (7.71, 10.3) p=0.8 9.05 (7.83, 10.16) p=0.9 8.91 (7.80, 9.80) p=0.6
30-min insulin (pmol/L) 396 (243, 743) 569 (368, 875) p=0.017 479* (333, 778) p=0.3 465* (271, 806) p=0.3
30-minute Δ insulin/Δglucose pmol/mmol 100 (50, 238) 150 (88, 238) p=0.001 138 (50, 200) p=0.2 113* (75, 188) p=0.057
120-min glucose, mmol/L 6.91 (5.27, 7.96) 6.83* (5.11, 8.05) p=0.2 6.97 (5.61, 8.63) p=0.1 6.02 (4.88, 7.49) p=0.3
120-min insulin, pmol/L 361 (236, 889) 396 (295, 608) p=0.2 375* (229, 993) p=0.2 299 (146, 611) p=0.4
Total glucose AUC, mmol/L•min•103 0.99 (0.87, 1.07) 0.97* (0.83, 1.13) p=0.4 0.98 (0.83, 1.14) p=0.3 0.92 (0.80, 1.03) p=0.4
Total insulin AUC, pmol/L•min•103 52.1 (31.3, 110.4) 70.1* (43.1, 123.6) p=0.025 69.5 (44.4, 106.3) p=0.11 50.7 (34.0, 87.5) p=0.9
Insulin sensitivity index [Matsuda, 1999 #2068] 4.0 (1.9, 5.6) 2.8 (1.8, 4.3) p=0.003 2.3* (1.4, 4.9) p=0.003 2.8 (2.0, 5.0) p=0.15

Results are given as median (interquartile range). p-values are Wilcoxon signed rank test, for comparison with week 4. N=32 for each value, except as noted:

*

N=31

N=30

N=29

N=28.